Trophic effects of continuous infusion of [Leu15]-gastrin-17 in the rat
Gastroenterology, 1990This report describes the trophic effects of exogenous gastrin on the digestive tract and pancreas and the effect on the density of enterochromaffinlike cells in the oxyntic mucosa of the stomach. Female rats were given 1.2 or 2.4 nmol/kg.h of synthetic human [Leu15]-gastrin-17 for 28 days (via osmotic minipumps implanted subcutaneously).
B, Ryberg +4 more
openaire +2 more sources
Effect of Gastrin-17 on Lower Esophageal Sphincter Characteristics in Man
Digestive Diseases and Sciences, 1997We studied the effect of gastrin-17 on lower esophageal sphincter (LES) characteristics in man. Nine healthy volunteers participated in two experiments performed in random order during continuous infusion of saline (control) or gastrin-17 (15 pmol/kg/hr).
J W, Straathof +2 more
openaire +2 more sources
Development of a time-resolved fluorescence immunoassay based on immunomagnetic beads for gastrin-17
Journal of Immunological Methods, 2021In this study, a novel, simple, and rapid immunoassay for the determination of gastrin-17 (G-17) in human serum was established by combining immunomagnetic beads with time-resolved fluorescence immunoassay (TRFIA).Immunomagnetic beads were coated with anti-G-17 M01 antibody, anti-G-17 M02 antibody was labeled with Eu3+ chelates.
Shaoxiong, Zheng +10 more
openaire +2 more sources
Gastrin 17 and Gastrin 34, Before and After a Meal, in Newborn Infants
Journal of Pediatric Gastroenterology and Nutrition, 1987SummaryIn 89 healthy full‐term newborn infants, we studied the different contribution of gastrin 17 (G17) and gastrin 34 (G34) to neonatal hypergastrinemia and the G17 and G34 response to a meal in the first days of life. Serum concentrations of G17 and G34 were measured by radioimmunoassay specific for the NH2‐terminus of G17 and G34 in 23 newborn ...
GEMELLI M +6 more
openaire +4 more sources
Immune response to gastrin-17 and survival in gastrointestinal cancers.
Journal of Clinical Oncology, 2010e14541 Background: Gastrin is a potential growth factor for tumors arising within the gastrointestinal tract.
J. M. Oortgiesen +6 more
openaire +1 more source
Probiotic intervention decreases serum gastrin-17 in Helicobacter pylori infection
Digestive and Liver Disease, 2007Previously we showed that a probiotic combination with L. rhamnosus GG was beneficial as an adjuvant therapy during H. pylori eradication.To evaluate whether probiotic combination with LGG adheres to the upper gastrointestinal mucosa and modifies H. pylori colonisation and H. pylori induced inflammation.Thirteen patients referred for gastroduodenoscopy
E, Myllyluoma +8 more
openaire +2 more sources
Phosphorylation of gastrin-17 by epidermal growth factor-stimulated tyrosine kinase
Nature, 1983Tyrosine phosphorylation seems to be a key event in the control of cellular growth. Several viral transforming proteins, including the src protein of Rous sarcoma virus, the p120 protein of Abelson leukaemia virus and the middle T antigen of polyoma virus, are phosphorylated by associated tyrosine kinases.
G S, Baldwin, J, Knesel, J M, Monckton
openaire +2 more sources
Acid Secretory Potency and Elimination of the 15-Leucine Gastrin-17 Analogue in Man
Scandinavian Journal of Gastroenterology, 1981The effect on gastric acid secretion and the elimination of a commercially available synthetic human gastrin analogue (15-Leucine Synthetic Human Gastrin I, 15-LSG) were studied in six healthy human subjects. On a molar basis acid secretory efficacy was approximately four times greater than pentagastrin and secretory potency ten times greater ...
B, Petersen +2 more
openaire +2 more sources
The N-terminal tridecapeptide fragment of gastrin-17 inhibits gastric acid secretion
Regulatory Peptides, 1983After a meal the serum concentrations of the N-terminal tridecapeptide-like fragment of gastrin-17, (1-13)G-17, increased markedly in patients with active duodenal ulcer, but less so in healthy subjects. Consequently the synthetic (1-13)G-17 was infused intravenously in doses that resulted in concentrations similar to those measured in duodenal ulcer ...
B, Petersen +2 more
openaire +2 more sources
Cholecystokinins but not gastrin-17 release calcitonin from thyroid C-cells in the rat
Regulatory Peptides, 1988Subcutaneous injections of gastrin-17, cholecystokinin-39, cholecystokinin-8 (sulfated and non-sulfated forms), cholecystokinin-4 or pentagastrin induced hypocalcemia in rats. The hypocalcemia was associated with calcitonin release for pentagastrin and the cholecystokinins but not for gastrin-17, even at very high doses.
P, Persson +4 more
openaire +2 more sources

